ÇмúÇà»ç

Korean Society of Gastrointestinal Cancer Research

Çмú´ëȸ ÀÚ·á½Ç

Á¦18ȸ ´ëÇѼÒÈ­±â¾Ï¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ

¼¼Á¾´ëÇб³ ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 2023-04-01

A Ȧ

Á¦18ȸ ´ëÇѼÒÈ­±â¾Ï¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ
08:30-09:00 µî·Ï
09:00-09:10 Àλ縻
Session I Mini-review of ASCO/ESMO GI Cancer Symposium (What¡¯s new in 2023) ÁÂÀå: ·ùÁö°ï (¼­¿ïÀÇ´ë), ÀÓÀ±Á¤(µ¿±¹ÀÇ´ë)
09:10-09:35 Esophageal/stomach cancer °­¼±Çü (Ãæ³²ÀÇ´ë)
09:35-10:00 Colorectal cancer ¿Àµ¿ÁØ (µ¿±¹ÀÇ´ë)
10:00-10:25 Pancreatobiliary cancer ½Åµ¿¿ì (ÇѸ²ÀÇ´ë)
10:25-10:45 Coffee break
Session II IASGO Joint Session : Debate or Controversial Issues of GI Cancer (English) ÁÂÀå: ¼Û½Ã¿µ(¿¬¼¼ÀÇ´ë), Kyoichi Takaori(Kyoto Univ., Japan)
10:45-11:10 Meaning of circulating tumor DNA in the colorectal cancer (KSGC) ±Ýº¸¶ó (°í·ÁÀÇ´ë)
11:10-11:35 Perioperative circulating tumor DNA as markers of colorectal cancer (IASGO) Scott Kopetz (The University of Texas, MD Anderson Cancer Center, USA)
11:35-12:00 Updates in perihilar cholangiocarcinoma - preoperative evaluation, drainage, and treatment - Gastroenterologist¡¯s viewpoint (KSGC) °­È­Æò (°¡ÃµÀÇ´ë)
12:00-12:25 Updates in perihilar cholangiocarcinoma - preoperative evaluation, drainage, and treatment - Surgeon¡¯s viewpoint (IASGO) Etsuro Hatano (Kyoto Univ., Japan)
Luncheon Symposium ±è¼º¼ö (°¡Å縯ÀÇ´ë)
12:25-12:50 Riding the new waves of success: the role of immune-oncology in Advanced BTC ¹æ½Â¹Î (¿¬¼¼ÀÇ´ë)
12:50-13:20 ´ëÇѼÒÈ­±â¾Ï¿¬±¸ÇÐȸ Á¤±âÃÑȸ
Session III Updates On the Treatment of Unresectable Pancreatic Cancer ÁÂÀå: ¹Ú½Â¿ì (¿¬¼¼ÀÇ´ë), ȲÁøÇõ (¼­¿ïÀÇ´ë)
13:20-13:45 Real-world outcomes of palliative chemotherapy for pancreatic cancer Á¶ÁßÇö (¿¬¼¼ÀÇ´ë)
13:45-14:10 Opportunities and benefits beyond second line chemotherapy ÀüÁß¿ø (±¹¸³¾Ï¼¾ÅÍ)
14:10-14:35 Emerging role of local ablation treatment ±è¸¸µæ (¿¬¼¼ÀÇ´ë ¿µ»óÀÇÇаú)
14:35-15:00 New treatment targets and therapeutic application ¹ÚÁÖ°æ (¼º±Õ°üÀÇ´ë)
15:00-15:20 Coffee break
Session IV À±¸®À§¿øȸ ¼¼¼Ç (Çʼö¼¼¼Ç) ÁÂÀå: ¹Úº´±Ô(±¹¹Î°Ç°­º¸ÇèÀϻ꺴¿ø), ±è¼ºÈÆ (ÀüºÏÀÇ´ë)
15:20-15:50 Ç×¾ÏÄ¡·á¿¡¼­ÀÇ ÀÇ·áÀ±¸®ÀÇ ¿ªÇÒ Á¶¹éÇö (±Â¸ð´×º´¿ø)
15:50-16:20 ¿¬¸íÀÇ·á °áÁ¤ Á¦µµ¿¡ ´ëÇÑ À±¸®Àû °íÂû ÇÑÁ¤È£ (ÃæºÏÀÇ´ë)
16:20-16:50 ºòµ¥ÀÌÅÍ¿Í ÀÇ·áÁ¤º¸ È°¿ëÀÇ À±¸®Àû ÀïÁ¡ ±Çº¹±Ô (ÀÌÈ­ÀÇ´ë ÀÇÇб³À°Çаú)
16:50-17:00 Best Presentation Award
17:00 ~ Adjourn

B Ȧ

Á¦18ȸ ´ëÇѼÒÈ­±â¾Ï¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ
Session I Gastrointestinal Cancer: Laboratory Bench to Clinic ÁÂÀå: ÀüÈÆÀç (°í·ÁÀÇ´ë), Á¤´ë¿µ (°¡Å縯ÀÇ´ë)
09:10-09:35 Machine learning application in GI cancer research from integrated omics data and discovery of clinical insights ±èÁ¤¾È (°í´ë±¸·Îº´¿ø ¾Ï¿¬±¸¼Ò)
09:35-10:00 Understanding microRNA as biomarkers and potential therapeutic targets in pancreatobiliary cancer ¹ÚÁø¼® (ÀÎÇÏÀÇ´ë)
10:00-10:25 Introduction to theranosis: an overview of current approaches and potential applicability to GI cancer ÀÓÀÏÇÑ (¿øÀڷº´¿ø ÇÙÀÇÇаú)
10:25-10:45 Coffee break
Session II Plenary Free Paper Presentation ÁÂÀå: ÁøÀ±Å (°í·ÁÀÇ´ë), ¹æ½Â¹Î (¿¬¼¼ÀÇ´ë)
10:45-11:00 ÃéÀå¾Ï¿¡¼­ ATR ¾ïÁ¦¸¦ ÅëÇÑ oxaliplatin ÀúÇ×¼º ±Øº¹¿¡ °üÇÑ ¿¬±¸ ÀüÁß¿ø (±¹¸³¾Ï¼¾ÅÍ)
11:00-11:15 Usefullness of endoscopic removal of occluded fully covered self-metallic stent in patients with malignant distal biliary obstruction À̽ÿµ (¿¬¼¼ÀÇ´ë)
11:15-11:30 Factors associated with gastric and duodenal neuroendocrine tumors: a multicenter case-control study in South Korea ³²±¤¿ì (´Ü±¹ÀÇ´ë)
11:30-11:45 Robot assisted gastric ESD significantly improves dissection speed in difficult ESD locations ±è»óÇö (°í·ÁÀÇ´ë)
11:45-12:00 A scoring model to predict the clinical outcome of self-expandable metal stents in patients with colorectal obstruction due to extracolonic malignancy ±èÀ±¾Æ (¿¬¼¼ÀÇ´ë)
12:25-12:50 (»ç) °Ç°­»çȸ¸¦ À§ÇÑ ¼ÒÈ­±â¾Ï ¿¬±¸È¸ Á¤±âÃÑȸ
12:50-13:20 Lunch
Session III Updates On the Treatment of Metastatic Gastrointestinal Tract Cancer ÁÂÀå: ±è¼º¼ö (°¡Å縯ÀÇ´ë), ¹Ú¼±ÀÚ(°í½ÅÀÇ´ë)
13:20-13:45 Treatment of colorectal cancer hepatic metastasis ÃÖ±âÈ« (¿¬¼¼ÀÇ´ë ¿Ü°ú)
13:45-14:10 Treatment of colorectal cancer lung metastasis °­¹Î¿õ (Ãæ³²ÀÇ´ë ÈäºÎ¿Ü°ú)
14:10-14:35 Conversion surgery after chemotherapy for inoperable gastric cancer ÀüÇÑÁ¶ (°í·ÁÀÇ´ë)
14:35-15:00 New targets and agents in upper GI cancer (other than HER2) ½É¼±Áø (°¡ÃµÀÇ´ë Á¾¾ç³»°ú)
15:00-15:20 Coffee break
Session IV Free Paper Presentation (1) ÁÂÀå: ÀÌÇ׶ô (ÇѾçÀÇ´ë), ÁÖ±¤·Î (°æÈñÀÇ´ë)
15:20-15:35 Prognosis prediction according to the expression level of immunochemistry staining using methionyl-tRNA synthetase 1 antibody in pancreatic cancer À强ÀÏ (¿¬¼¼ÀÇ´ë)
15:35-15:50 Augmented effect of irreversible electroporation following near-infrared irradiation on gastric neoplasm: an experimental study ±èµ¿È¯ (°í·ÁÀÇ´ë)
15:50-16:05 Prediction of LN metastasis from whole slide pathology images of early gastric cancer using a two step machine learning approach À̺¸¹Ì (°í·ÁÀÇ´ë)
Session IV Free Paper Presentation (2) ÁÂÀå: ¹®Á¤¼· (ÀÎÁ¦ÀÇ´ë), ¿ì»ó¸í (±¹¸³¾Ï¼¾ÅÍ)
16:00-16:20 Novel liquid biopsy strategy for cholangiocarcinoma diagnosis based on plasmon-enhanced single extracellular vesicle analysis Á¶ÁßÇö (¿¬¼¼ÀÇ´ë)
16:20-16:35 Risk factors for early and late-onset cholecystitis after y-configured metal stent placement in patients with malignant hilar obstruction: a single-center experience ÀÌÁ¾Çö (ºÎ»êÀÇ´ë)
16:35-16:50 Effect of ultra-processed food intake on the risk of colorectal cancer: results from two nationwide long-term follow-up studies in Korea ÃÖÀ±ÀÌ (±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø)
16:50-17:00 Best Presentation Award
17:00 ~ Adjourn